Clinical Trials Directory

Trials / Completed

CompletedNCT05061485

The Effect of Macronutrients on Fibroblast Growth Factor 21 (FGF21) Secretion

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of Copenhagen · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The aim of this randomized cross-over study is to investigate how consumption of protein and fat affects the FGF21 response triggered by sucrose. The hypothesis is that the consumption of protein, but not fat, will attenuate the FGF21 response triggered by sucrose. Exploratory, and in order to investigate mechanisms behind the potential attenuation in the sucrose-induced FGF21 response after protein consumption, glucose, insulin, glucagon, triglycerides, amino acids, glicentin and cholecystokinin (CCK) will be assessed before and after consumption of sucrose, sucrose+protein and sucrose+fat. Furthermore, the association between the FGF21 response after consumption of sucrose, sucrose + protein and sucrose + fat and subjective rating of appetite for sweet will also be investigated.

Conditions

Interventions

TypeNameDescription
OTHERSucroseThe participants consume A) water with 75 g sucrose
OTHERSucrose + proteinThe participants consume B) water with 75 g sucrose + approx. 100 kcal protein
OTHERSucrose + fatThe participants C) water with 75 g sucrose + approx. 100 kcal fat

Timeline

Start date
2021-09-28
Primary completion
2022-02-23
Completion
2022-02-23
First posted
2021-09-29
Last updated
2022-03-31

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT05061485. Inclusion in this directory is not an endorsement.